TY  - JOUR

T1  - A Salvage Autologous Stem Cell Transplant (ASCT2) Induces Superior Overall Survival Following Bortezomib-Containing Re-Induction Therapy for Relapsed Multiple Myeloma (MM): Results from the Myeloma X (Intensive) Trial

JO  - Blood

PY  - 2015/12/03

AU  - Cook G

AU  - Williams C

AU  - Cairns DA

AU  - Hockaday A

AU  - Cavenagh J

AU  - Snowden JA

AU  - Parrish C

AU  - Yong KL

AU  - Cavet J

AU  - Hunter H

AU  - Bird J et al

ED  - 

DO  - DOI: 10.1182/blood.v126.23.394.394

PB  - American Society of Hematology

VL  - 126

IS  - 23

SP  - 394

EP  - 394

Y2  - 2024/12/22

ER  -